These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Reproducibility of grading systems in oral epithelial dysplasia. Manchanda A; Shetty DC Med Oral Patol Oral Cir Bucal; 2012 Nov; 17(6):e935-42. PubMed ID: 22549675 [TBL] [Abstract][Full Text] [Related]
23. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up. Arduino PG; Surace A; Carbone M; Elia A; Massolini G; Gandolfo S; Broccoletti R J Oral Pathol Med; 2009 Jul; 38(6):540-4. PubMed ID: 19453839 [TBL] [Abstract][Full Text] [Related]
24. Epithelial dysplasia of the oral cavity and lips. Kaugars GE; Burns JC; Gunsolley JC Cancer; 1988 Nov; 62(10):2166-70. PubMed ID: 3179929 [TBL] [Abstract][Full Text] [Related]
30. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430 [TBL] [Abstract][Full Text] [Related]
31. Erythroplakia of the oral cavity. Shafer WG; Waldron CA Cancer; 1975 Sep; 36(3):1021-8. PubMed ID: 1182656 [TBL] [Abstract][Full Text] [Related]
32. Immunoexpression of tenascin as a predictor of the malignancy potential of oral leukoplakia associated with a tobacco habit. Mane DR; Bhat K; Kale AD; Hallikerimath S Biotech Histochem; 2015; 90(7):544-51. PubMed ID: 25839195 [TBL] [Abstract][Full Text] [Related]
33. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study. Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424 [TBL] [Abstract][Full Text] [Related]
34. Oral potentially malignant disorders in a large dental population. Villa A; Gohel A J Appl Oral Sci; 2014; 22(6):473-6. PubMed ID: 25591015 [TBL] [Abstract][Full Text] [Related]
35. Epidemiology and correlation of the clinicopathological features in oral epithelial dysplasia: analysis of 173 cases. Pereira Jdos S; Carvalho Mde V; Henriques AC; de Queiroz Camara TH; Miguel MC; Freitas Rde A Ann Diagn Pathol; 2011 Apr; 15(2):98-102. PubMed ID: 21190879 [TBL] [Abstract][Full Text] [Related]
36. Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia. Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Martinez-Lara I Head Neck; 2000 Oct; 22(7):658-61. PubMed ID: 11002319 [TBL] [Abstract][Full Text] [Related]
37. Anatomic site based ploidy analysis of oral premalignant lesions. Islam MN; Kornberg L; Veenker E; Cohen DM; Bhattacharyya I Head Neck Pathol; 2010 Mar; 4(1):10-4. PubMed ID: 20237983 [TBL] [Abstract][Full Text] [Related]
38. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment. Awan Kh; Yang Y; Morgan P; Warnakulasuriya S Oral Dis; 2012 Nov; 18(8):728-33. PubMed ID: 22524200 [TBL] [Abstract][Full Text] [Related]
39. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Coltrera MD; Zarbo RJ; Sakr WA; Gown AM Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338 [TBL] [Abstract][Full Text] [Related]
40. Focal epithelial hyperplasia. A rare disease in our area. Segura-Saint-Gerons R; Toro-Rojas M; Ceballos-Salobreña A; Aparicio-Soria JL; Fuentes-Vaamonde H Med Oral Patol Oral Cir Bucal; 2005; 10(2):128-31. PubMed ID: 15735545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]